Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors

Non-alcoholic steatohepatitis (NASH) and resultant liver fibrosis is a major health problem without effective therapy. Some data suggest that galectin-3 null mice are resistant to the development of NASH with fibrosis. We examined the ability of two complex carbohydrate drugs that bind galectin-3, G...

Descripción completa

Detalles Bibliográficos
Autores principales: Traber, Peter G., Zomer, Eliezer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867460/
https://www.ncbi.nlm.nih.gov/pubmed/24367597
http://dx.doi.org/10.1371/journal.pone.0083481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867460/
https://www.ncbi.nlm.nih.gov/pubmed/24367597
http://dx.doi.org/10.1371/journal.pone.0083481

Ejemplares similares